• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析依维莫司洗脱生物可吸收血管支架支架后斑块 1 年的虚拟组织学变化。

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.

机构信息

Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, 's Gravendijkwal 230, 3015, Rotterdam, CE, The Netherlands.

出版信息

Int J Cardiovasc Imaging. 2012 Aug;28(6):1307-14. doi: 10.1007/s10554-011-9981-4. Epub 2011 Nov 23.

DOI:10.1007/s10554-011-9981-4
PMID:22108907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3463791/
Abstract

Serial intravascular ultrasound virtual histology (IVUS-VH) after implantation of metallic stents has been unable to show any changes in the composition of the scaffolded plaque overtime. The everolimus-eluting ABSORB scaffold potentially allows for the formation of new fibrotic tissue on the scaffolded coronary plaque during bioresorption. We examined the 12 month IVUS-VH changes in composition of the plaque behind the struts (PBS) following the implantation of the ABSORB scaffold. Using IVUS-VH and dedicated software, the composition of the PBS was analyzed in all patients from the ABSORB Cohort B2 trial, who were imaged with a commercially available IVUS-VH console (s5i system, Volcano Corporation, Rancho Cordova, CA, USA), immediately post-ABSORB implantation and at 12 month follow-up. Paired IVUS-VH data, recorded with s5i system, were available in 17 patients (18 lesions). The analysis demonstrated an increase in mean PBS area (2.39 ± 1.85 mm(2) vs. 2.76 ± 1.79 mm(2), P = 0.078) and a reduction in the mean lumen area (6.37 ± 0.90 mm(2) vs. 5.98 ± 0.97 mm(2), P = 0.006). Conversely, a significant decrease of 16 and 30% in necrotic core (NC) and dense calcium (DC) content, respectively, were evident (median % NC from 43.24 to 36.06%, P = 0.016; median % DC from 20.28 to 11.36%, P = 0.002). Serial IVUS-VH analyses of plaque located behind the ABSORB struts at 12-month demonstrated an increase in plaque area with a decrease in its NC and DC content. Larger studies are required to investigate the clinical impact of these findings.

摘要

在金属支架植入后,连续的血管内超声虚拟组织学(IVUS-VH)未能显示支架斑块的组成随时间的任何变化。依维莫司洗脱 ABSORB 支架在生物吸收过程中可能会在支架冠状动脉斑块上形成新的纤维组织。我们检查了 ABSORB 支架植入后支架小梁后(PBS)斑块的 12 个月 IVUS-VH 成分变化。使用 IVUS-VH 和专用软件,对 ABSORB Cohort B2 试验中所有患者的 PBS 成分进行了分析,这些患者使用商业 IVUS-VH 控制台(s5i 系统,Volcano Corporation,Rancho Cordova,CA,USA)进行成像,即刻在 ABSORB 植入后和 12 个月随访时。记录在 s5i 系统上的配对 IVUS-VH 数据可用于 17 名患者(18 个病变)。分析显示 PBS 面积的均值增加(2.39 ± 1.85 mm2 比 2.76 ± 1.79 mm2,P = 0.078),管腔面积的均值减少(6.37 ± 0.90 mm2 比 5.98 ± 0.97 mm2,P = 0.006)。相反,坏死核心(NC)和致密钙(DC)含量分别明显减少 16%和 30%(NC 中位数从 43.24%降至 36.06%,P = 0.016;DC 中位数从 20.28%降至 11.36%,P = 0.002)。12 个月时 ABSORB 支架小梁后斑块的连续 IVUS-VH 分析显示,斑块面积增加,NC 和 DC 含量减少。需要更大的研究来探讨这些发现的临床影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/1dd81e05a10e/10554_2011_9981_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/305bfa927507/10554_2011_9981_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/9159873ae31b/10554_2011_9981_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/1dd81e05a10e/10554_2011_9981_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/305bfa927507/10554_2011_9981_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/9159873ae31b/10554_2011_9981_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c41/3463791/1dd81e05a10e/10554_2011_9981_Fig3_HTML.jpg

相似文献

1
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.分析依维莫司洗脱生物可吸收血管支架支架后斑块 1 年的虚拟组织学变化。
Int J Cardiovasc Imaging. 2012 Aug;28(6):1307-14. doi: 10.1007/s10554-011-9981-4. Epub 2011 Nov 23.
2
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.载有依维莫司的可吸收血管支架梁后部位的冠状动脉斑块的时间变化。
Int J Cardiovasc Imaging. 2011 Jul;27(6):859-66. doi: 10.1007/s10554-010-9724-y. Epub 2010 Oct 13.
3
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.ABSORB 依维莫司洗脱可吸收生物血管支架近端和远端边缘节段的血管反应:6 个月和 1 年随访评估:来自首例人体 ABSORB 队列 B 试验的虚拟组织学血管内超声研究。
JACC Cardiovasc Interv. 2012 Jun;5(6):656-65. doi: 10.1016/j.jcin.2012.02.017.
4
Reproducibility of Shin's method for necrotic core and calcium content in atherosclerotic coronary lesions treated with bioresorbable everolimus-eluting vascular scaffolds using volumetric intravascular ultrasound radiofrequency-based analysis.应用基于容积血管内超声射频分析的生物可吸收依维莫司洗脱血管支架治疗动脉粥样硬化性冠状动脉病变时,Shin 法测定坏死核心和钙含量的可重复性。
Int J Cardiovasc Imaging. 2012 Jan;28(1):43-9. doi: 10.1007/s10554-010-9779-9. Epub 2011 Jan 13.
5
Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.生物可吸收依维莫司洗脱支架植入后吸收过程的评估:使用血管内超声射频数据分析应变值和组织成分的时间变化。ABSORB临床试验的一项子研究。
EuroIntervention. 2009 Jan;4(4):443-8. doi: 10.4244/eijv4i4a77.
6
Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study.应用 Shin 方法评估生物可吸收依维莫司洗脱血管支架治疗粥样硬化性冠状动脉病变血管壁内容物的系列变化:一项 IVUS 研究。
Int J Cardiovasc Imaging. 2011 Oct;27(7):931-7. doi: 10.1007/s10554-010-9739-4. Epub 2010 Nov 16.
7
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.第一代和第二代生物可吸收血管支架的比较:一项 6 个月的虚拟组织学研究。
EuroIntervention. 2011 Apr;6(9):1110-6. doi: 10.4244/EIJV6I9A193.
8
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果:ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
9
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial.植入后 12 个月内依维莫司洗脱生物可吸收血管支架的血管内超声回声变化:ABSORB B 试验的见解。
JACC Cardiovasc Interv. 2011 Dec;4(12):1281-9. doi: 10.1016/j.jcin.2011.08.014.
10
Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.在Absorb II研究中,对依维莫司洗脱生物可吸收血管支架或依维莫司洗脱金属支架植入后即刻的三种血管内超声模式下“斑块/中膜”变化进行比较评估。
Int J Cardiovasc Imaging. 2017 Apr;33(4):441-449. doi: 10.1007/s10554-016-1033-7. Epub 2016 Dec 23.

引用本文的文献

1
Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱支架治疗冠状动脉慢性完全闭塞的疗效长期随访:冠状动脉内成像引导的比较研究
Egypt Heart J. 2020 Oct 21;72(1):72. doi: 10.1186/s43044-020-00104-x.
2
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis.生物可吸收血管支架与药物洗脱支架治疗冠心病的Meta分析
J Cardiothorac Surg. 2020 Jan 28;15(1):26. doi: 10.1186/s13019-020-1041-5.
3

本文引用的文献

1
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.第二代生物可吸收依维莫司洗脱血管支架治疗初发冠状动脉狭窄的评估:12 个月临床和影像学结果。
J Am Coll Cardiol. 2011 Oct 4;58(15):1578-88. doi: 10.1016/j.jacc.2011.05.050.
2
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.第一代和第二代生物可吸收血管支架的比较:一项 6 个月的虚拟组织学研究。
EuroIntervention. 2011 Apr;6(9):1110-6. doi: 10.4244/EIJV6I9A193.
3
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry.
金属支架与依维莫司洗脱生物可吸收血管支架的混合冠状动脉经皮治疗:来自GABI-R注册研究的2年结果
J Clin Med. 2019 May 30;8(6):767. doi: 10.3390/jcm8060767.
4
A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.XINSORB生物可吸收西罗莫司洗脱支架与金属西罗莫司洗脱支架的头对头比较:猪模型180天随访
Int J Cardiovasc Imaging. 2017 Oct;33(10):1473-1481. doi: 10.1007/s10554-017-1148-5. Epub 2017 Jun 21.
5
Ultrasound Vascular Elastography as a Tool for Assessing Atherosclerotic Plaques - A Systematic Literature Review.超声血管弹性成像作为评估动脉粥样硬化斑块的工具——一项系统文献综述
Ultrasound Int Open. 2016 Nov;2(4):E106-E112. doi: 10.1055/s-0042-115564. Epub 2016 Oct 13.
6
Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.作为生物可吸收依维莫司洗脱支架降解替代指标的回声性:在猪模型中进行的1、3、6、12、18、24、30、36和42个月随访分析
Int J Cardiovasc Imaging. 2015 Mar;31(3):471-82. doi: 10.1007/s10554-015-0591-4. Epub 2015 Jan 28.
7
The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology.新型生物可吸收支架对冠状动脉病理生理学的影响。
J Cardiovasc Transl Res. 2014 Jun;7(4):413-25. doi: 10.1007/s12265-014-9571-7. Epub 2014 May 7.
8
Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.《国际心血管影像杂志》2012年心血管成像相关内容
Int J Cardiovasc Imaging. 2013 Apr;29(4):725-36. doi: 10.1007/s10554-013-0216-8.
9
Absorbable stent: focus on clinical applications and benefits.可吸收支架:聚焦临床应用与益处
Vasc Health Risk Manag. 2012;8:125-32. doi: 10.2147/VHRM.S22551. Epub 2012 Feb 29.
光学相干断层成像术对第一代和第二代依维莫司洗脱生物可吸收血管支架性能的比较评估。
Eur Heart J. 2011 Feb;32(3):294-304. doi: 10.1093/eurheartj/ehq458. Epub 2010 Dec 1.
4
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.第二代生物可吸收依维莫司药物洗脱血管支架治疗冠状动脉原发狭窄的临床和影像学 6 个月随访结果。
Circulation. 2010 Nov 30;122(22):2301-12. doi: 10.1161/CIRCULATIONAHA.110.970772. Epub 2010 Nov 15.
5
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.在猪冠状动脉模型中植入依维莫司洗脱可吸收血管支架 1 个月、2 个月、3 个月和 4 年后的冠状动脉内光学相干断层成像和组织学:尝试解读 ABSORB 试验中的人类光学相干断层成像图像。
Circulation. 2010 Nov 30;122(22):2288-300. doi: 10.1161/CIRCULATIONAHA.109.921528. Epub 2010 Oct 25.
6
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.载有依维莫司的可吸收血管支架梁后部位的冠状动脉斑块的时间变化。
Int J Cardiovasc Imaging. 2011 Jul;27(6):859-66. doi: 10.1007/s10554-010-9724-y. Epub 2010 Oct 13.
7
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting.基于血管内射频数据分析的组织特征分析:采集、分析、解读及报告建议。
EuroIntervention. 2009 Jun;5(2):177-89. doi: 10.4244/eijv5i2a29.
8
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound.采用虚拟组织学血管内超声分析药物洗脱支架对冠状动脉壁形态的长期影响。
Am Heart J. 2010 Feb;159(2):271-7. doi: 10.1016/j.ahj.2009.11.008.
9
IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process.在生物吸收过程中评估可吸收性依维莫司洗脱装置的聚合物支杆时的血管内超声(IVUS)射频分析。
Catheter Cardiovasc Interv. 2010 May 1;75(6):914-8. doi: 10.1002/ccd.22332.
10
Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.通过容积虚拟组织学血管内超声分析评估他汀类药物治疗对冠状动脉斑块的影响。
JACC Cardiovasc Interv. 2009 Jul;2(7):679-88. doi: 10.1016/j.jcin.2009.03.015.